NOV 21, 2015 6:28 AM PST

Pneumophages as Alternative Treatment for Pneumonia

WRITTEN BY: Sarah Hertrich
Staphylococcus pneumoniae are a species of bacteria known for their significant impact on the upper respiratory tract. The bacterium was first isolated in 1881 by Louis Pasteur. It was also used in the experiments that led to the discovery of bacterial transformation in 1928 by Frederick Griffith as well as in 1944 by MacLeod and McCarthy to show that genetic material is DNA as it was originally thought to be protein. S. pneumoniae are primarily found in the respiratory tract throughout the throat and nasal cavities. It is the causative agent of many different types of infections including pneumonia, sepsis, meningitis and otitis media.
 
Bacteriophages are viruses that infect bacteria and are being tested as an alternative therapy to treat bacterial infections such as pneumonia.


Over the last 20 years, the bacteria have shown a significant increase in resistance to antibiotics. Scientists suspect this resistance in due to the use of a natural transformation system used for genetic exchange. The emergence of β-lactam resistant pneumococci is a major health burden due to the spread of multiresistant bacterial clones. As a result, scientists are searching for alternatives to traditional antibiotics for the treatment of S. pneumoniae infections.

Researchers from the University of Laval in Quebec, Canada published a study in BMC Genomics investigating the use of pneumophages (bacteriophages that infect S. pneumoniae) as a potential treatment for pneumonia infections as well as how the phage and the bacterial host interact with one another. Researchers used bacteriophage insensitive S. pneumonia mutants and performed whole genome sequencing on mutants as well as a reference genome to detect single nucleotide polymorphisms within the genome of mutants. This technique would help them determine the genes that lead to phage resistance in bacteria.



They found that the unencapsulated S. pneumonia mutant was much more sensitive to pneumophages than the wild type strains. They concluded that the pneumococcal serotype 2 capsule is a major determinant in resistance against pneumophages. Phage adsorption experiments showed that the part of the infective cycle blocked by bacterial mutants is a step of the lytic cycle. They also concluded that phage resistance occurs very early in the infection cycle. Whole genome sequencing revealed that GntR-like bacterial transcription factors are responsible for resistance of S. pneumoniae to the pneumophages used in this experiment.

Researchers highlighted that a diverse array of host genes in S. pneumoniae are involved in the replication of phages from different types of phage families. Further research is needed regarding phage-host interactions to optimize the use of bacteriophages to treat bacterial infections as an alternative therapy to traditional antibiotics.

Sources: BMC Genomics; Microbe Wiki; University of Oklahoma; University of Utah; BROAD Institute
 
About the Author
  • I am a postdoctoral researcher with interests in pre-harvest microbial food safety, nonthermal food processing technologies, zoonotic pathogens, and plant-microbe interactions. My current research projects involve the optimization of novel food processing technologies to reduce the number of foodborne pathogens on fresh produce. I am a food geek!
You May Also Like
MAR 18, 2020
Cell & Molecular Biology
MAR 18, 2020
Researchers Devise a Way to Model Membraneless Organelles
Like mixing oil and water, cells use phase separation to organize and separate their contents.
MAR 22, 2020
Cell & Molecular Biology
MAR 22, 2020
Capturing Images of Firing Neurons
Our bodies run on electricity. Neurons send rapidly fired electrical signals through the brain and limbs constantly, ena ...
APR 02, 2020
Chemistry & Physics
APR 02, 2020
How Particle Physicists can Lend a Hand to the Search for SARS-CoV-02 Cure, Explained
With vaccines at least one year away and no proven treatment for infection, the world has witnessed the loss of  20 ...
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job do ...
APR 02, 2020
Cell & Molecular Biology
APR 02, 2020
Cooling Injured Brain Cells Can Aid Recovery
According to the CDC, in 2014 there were around 2.87 million incidences of TBI-related ER visits.
MAY 25, 2020
Cell & Molecular Biology
MAY 25, 2020
Rewrite the Books: Retinoic Acid Does Not Trigger Meiosis
Researchers are challenging what we thought we knew about the mechanism of sexual reproduction.
Loading Comments...